https://www.sciencedirect.com/science/a ... 6523000934
Highlights
• Rapid and novel screening test of blood fraction reveals the biochemical fingerprint of multiple sclerosis (MS).
• Raman spectroscopy (RS) disclose alterations mainly in plasma and serum carotenoids during MS progression.
• Unambiguous differentiation between healthy and MS patients by multivariate techniques.
• Potential of lipid and carotenoid molecules as useful biomarkers which may be applied for both diagnosis and treatment monitoring of MS.
Graphical abstract:
